Suberoylanilide hydroxamic acid enhances the antitumor activity of oxaliplatin by reversing the oxaliplatin-induced Src activation in gastric cancer cells

Chenfei Zhou(Ruijin Hospital), Jun Zhang(Shenzhen University Health Science Center)
Molecular Medicine Reports
September 9, 2014
Cited by 12


Related Papers